Table of Contents
The components of deferred tax assets and liabilities were as follows:
As of December 31,
2016 2015
(in thousands)
IDeferred tax assets (liabilities): I
Stock-based compensation $ 188,458 $ 131,339
I Accruals and reserves 29,231 14,367 I
Depreciation and amortization (93,760) (43,204)
I R&D credits 107,283 74,091 I
Other (2,363) 3,980
I Gross deferred tax assets 228,849 180,573 I
Valuation allowance (1,601) —
INet deferred tax assets $ 227,248 $ 180,573 I
All deferred tax assets are classified as “Other non-current assets” on the Consolidated Balance Sheets as of December 31, 2016 and December 31, 2015 . In
evaluating its ability to realize the net deferred tax assets, the Company considered all available positive and negative evidence, including its past operating results
and the forecast of future market growth, forecasted earnings, future taxable income, and prudent and feasible tax planning strategies. As of December 31, 2016
and 2015 , it was considered more likely than not that substantially all deferred tax assets would be realized, and no signiﬁcant valuation allowance was recorded.
As of December 31, 2016 , the Company's Federal R&D tax credit and state tax credit carryforwards for tax return purposes were $72.5 million , and $77.7
million , respectively. The Federal R&D tax credit carryforwards expire through 2036. State tax credit carryforwards of $77.3 million can be carried forward
indefinitely and $0.4 million expire in 2024.
As of December 31, 2016 , the Company’s net operating loss carryforwards for Federal and state tax return purposes were $108.9 million and $100.0 million
, respectively, which expire in 2035. These net operating losses were generated as a result of excess stock option deductions. Pursuant to Accounting Standards
Codiﬁcation 718, Compensation - Stock Compensation , the Company has not recognized the related $45.1 million tax beneﬁt from the Federal and state net
operating losses attributable to excess stock option deductions in gross deferred tax assets. The $45.1 million tax beneﬁt will be credited directly to additional paid-
in capital when net operating losses attributable to excess stock option deductions are utilized to reduce taxes payable.
Income tax benefits attributable to the exercise of employee stock options of $64.3 million , $79.9 million and $88.9 million for the years ended
December 31, 2016 , 2015 and 2014 , respectively, were recorded directly to additional paid-in—capital.
The unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year are classified as “Other non-current liabilities” and
a reduction of deferred tax assets which is classified as "Other non-current assets" in the Consolidated Balance Sheets. As of December 31, 2016 , the total amount
of gross unrecognized tax beneﬁts was $19.7 million , of which $17.0 million , if recognized, would favorably impact the Company’s effective tax rate. As of
December 31, 2015 , the total amount of gross unrecognized tax benefits was $17.1 million , of which $13.5 million , if recognized, would favorably impact the
Company’s effective tax rate. The aggregate changes in the Company’s total gross amount of unrecognized tax benefits are summarized as follows (in thousands):
IBalances as of December 31, 2014 $ 34,812 I
Increases related to tax positions taken during prior periods 1,960
I Decreases related to tax positions taken during prior periods (12,334) I
Increases related to tax positions taken during the current period 7,077
I Decreases related to settlements with taxng authorities (14,398) I
Balances as of December 31, 2015 17,117
I Increases related to tax positions taken during prior periods 1,047 I
Decreases related to tax positions taken during prior periods (7,105)
I Increases related to tax positions taken during the current period 8,713 I
Decreases related to expiration of statute of limitations (33)
IBalances as of December 31, 2016 $ 19,739 I
58